Skip to main content

HMG

Source index · checked quotations available

An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.

Source summary generated November 6, 2026; this date does not indicate completed review.

Hormones169 cited mentionsAliases: Human Menopausal Gonadotropin
Track your own protocol free →

Quotes from three independent practitioners, with their sources. Research context only.

What it is and how it works

From the published literature on HMG; the papers are listed at the end. Research summary, not a recommendation.

What it is

Human menopausal gonadotropin (hMG, menotropins) is a mixture of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity purified from the urine of postmenopausal women, whose pituitaries secrete large amounts of both. It was introduced in the 1960s and remains a prescription fertility drug; modern preparations are highly purified and part of the LH activity comes from hCG that co-purifies.

How it works

FSH acts on Sertoli cells in the testis to drive sperm production and on granulosa cells in the ovary to grow follicles; LH acts on Leydig cells to make testosterone and on theca cells to make the androgen precursors of estrogen. hMG supplies both signals from outside the body, so it can replace a missing pituitary signal (hypogonadotropic hypogonadism) or push the ovary to grow several follicles at once for IVF. In men it is usually combined with hCG once testosterone has been restored and sperm production has not started.

What it has been studied for

  • Inducing sperm production in men with hypogonadotropic hypogonadism (with hCG)
  • Controlled ovarian stimulation for IVF and ovulation induction in women
  • Pubertal induction in boys with gonadotropin deficiency
  • Comparison against recombinant FSH in assisted reproduction

Strength of the evidence

Approved drugMenotropins are FDA-approved for ovulation induction, assisted reproduction and spermatogenesis induction, supported by Cochrane meta-analyses and clinical series.

What the literature reports on safety

The main risks are ovarian hyperstimulation syndrome, multiple pregnancy and injection-site reactions in women; in men gynecomastia and acne have been reported. It is contraindicated in primary gonadal failure, uncontrolled thyroid or adrenal disease and hormone-dependent tumors. It requires monitoring with hormone levels and ultrasound.

Key papers

  1. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism. (opens in a new tab)

    Review · Boeri L, Capogrosso P, et al. · Curr Pharm Des (2021) · PMID 32445446

    Reviewed hCG plus FSH/hMG regimens for men with hypogonadotropic hypogonadism, with sperm appearing in most men after months of combined treatment.

  2. Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis. (opens in a new tab)

    Review · Alexander EC, Faruqi D, et al. · Eur J Endocrinol (2024) · PMID 38128110

    Pooled evidence that combined gonadotropins induced testicular growth and sperm production in adolescents and young men.

  3. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. (opens in a new tab)

    Review · Van Wely M, Westergaard LG, et al. · Cochrane Database Syst Rev (2003) · PMID 12535497

    Cochrane comparison found hMG and recombinant FSH gave similar pregnancy outcomes in IVF.

  4. Recombinant follicle-stimulating hormone (rFSH) versus other recombinant or urinary gonadotropins for ovarian stimulation in assisted reproductive technology cycles. (opens in a new tab)

    Review · Berkhout RP, Kostova EB, et al. · Cochrane Database Syst Rev (2026) · PMID 42445958

    Updated Cochrane review found no clear difference in live birth or hyperstimulation between urinary gonadotropins such as hMG and recombinant FSH.

  5. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. (opens in a new tab)

    Case series · Büchter D, Behre HM, et al. · Eur J Endocrinol (1998) · PMID 9758439

    hCG/hMG restored sperm production in most men with hypogonadotropic hypogonadism, with results comparable to pulsatile GnRH.

  6. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. (opens in a new tab)

    Case series · Ley SB, Leonard JM · J Clin Endocrinol Metab (1985) · PMID 3928676

    Identified baseline testicular size and prior androgen exposure as predictors of response to hCG/hMG.

Sources checked: PubMed/PMC (E-utilities), Cochrane via PubMed, FDA label via DailyMed, written 2026-11-06.

Hunter Williams, in his own words

Figures quoted, not recommended. These are Hunter Williams' descriptions, not an agreed treatment protocol.

5 quotations from his library pages, each with its source. A quote marked with a product name is about a blend that includes HMG.

What he says it is for

His stated dose, protocol and cycle

Stacks he pairs it with

Cautions he raises

Figures quoted from the practitioner named. We cite, we do not recommend.

Hunter Williams

→ profile

Protocol systematizer

Taylor Williams

→ profile

Female-focused HRT + peptides

5 earlier videos were removed from YouTube; titles kept for the record
  • Saturday Morning Coffee Talk 1/17/26 (15×) · 2026-01-17
  • Saturday Morning Coffee Talk 3/28/26 (6×) · 2026-03-28
  • Saturday Morning Coffee Talk 1/3/2026 (3×) · 2026-01-04
  • Saturday Morning Coffee Talk | 2/7/26 (3×) · 2026-02-08
  • Saturday Morning Coffee Talk 2/28/26 (3×) · 2026-02-28

Dr Trevor Bachmeyer

→ profile

Acute vs chronic specialist

Source index (6); article review incomplete
5 earlier videos were removed from YouTube; titles kept for the record
  • The Proof That Healthcare is a Business - Unbreakable Podcast 200 (6×) · 2025-07-20
  • The Lie About High Cholesterol - Unbreakable Podcast 263 (6×) · 2025-09-24
  • The FDA War Against Peptides and The Facts - Dr Trevor Bachmeyer (6×) · 2026-02-13
  • Why You Can't Talk About It - Unbreakable Podcast 257 (3×) · 2025-09-18
  • KPV and TB500N vs Cholesterol, AFib and Heart Disease - Dr Trevor Bachmeyer (3×) · 2026-03-22

Ask the HMG Librarian

Answers are generated from captured sources and may omit context or contain errors. Check the supporting passages.

What have the teachers said about HMG? Ask what it is, what they say it does, or where they discuss it. Questions about doses or personal use: ask your own clinician.

AI chat. To generate a reply, your question and recent chat history may be processed by Cloudflare Workers AI, Groq, Google Gemini or OpenRouter, depending on availability. Keep personal health details out of the chat and check the cited sources. Research use only; not medical advice.

Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.

Disclaimer: for research purposes only

All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.

HMG — Hunter, Taylor, Bachmeyer | Reset Biology